Emma Whited | e4485835b54 | Edited cder_sir_wp007 description | | |
Emma Whited | c0c623a77e8 | Edited cder_sir_wp007 description | | |
Emma Whited | f296150b675 | Edited cder_sir_wp007 description | | |
Whited | bb76391ba1c | Sentinel Query: cder_sir_wp007_public_v01 | | |
Aaron Madow | ac2414b7662 | Added cder_sir_wp009 | | |
Lizzie Beers | 59dc8084b12 | added cder_mpl2p_wp039, cder_mpl2p_wp044, and cder_mpl2p_wp047 | | |
Emma Whited | f0de93eb50b | Added Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis and Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified Analysis | | COVID-19 |
Lizzie Beers | e398c3af94a | added Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis | | COVID-19 |
Lizzie Beers | c18f58bfb4b | Added Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis | | COVID-19 |
Lizzie Beers | cd76ab78330 | added Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis | | COVID-19 |
Whitney Chlon | 73405bbfda1 | Added Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis and Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis | | GLP-1 |
Emma Whited | ef4bb477d97 | Added Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis | | |
Lizzie Beers | 55057bbd3c0 | Added Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis | | |
Lizzie Beers | 74bd440a81f | Added Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis | | |
Emma Whited | 13545dab23b | Added Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis | | |
Emma Whited | 51e68e63dd8 | Added Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis | | |
Lizzie Beers | 1765e67a95d | Added Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding | | ICD-10 |
Lizzie Beers | 5a24c312d0d | Added Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis | | |
Lizzie Beers | 804cab111ce | Added Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis | | |
Emma Whited | 7746ff956ba | updated cder_mpl2p_wp023 title | | |
Emma Whited | ed6dec4e481 | added cder_mpl2p_wp043 | | |
Emma Whited | 8307da78fdc | added cder_mpl2r_wp018 | | |
Lizzie Beers | 5ae7df5bf64 | added cder_sir_wp004 | | |
Whitney Chlon | dc2fde8b66d | Added Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Analysis | | |
Lizzie Beers | 61a200827cf | Added cder_mpl2r_wp019 | | |
Whitney Chlon | dc100c0a709 | readme.md edited online with Bitbucket | | |
Whitney Chlon | 8b5979d5b90 | readme.md edited online with Bitbucket | | |
Whitney Chlon | 0300eeb0a1a | Added Race and Ethnicity Associations Among Patients Hospitalized with COVID-19: A Covariate Stratified Analysis | | COVID-19 |
Emma Whited | a6cfabd103a | readme.md edited online with Bitbucket | | |
Lizzie Beers | 05128291a77 | added cder_mpl1p_wp072 and cder_mpl1p_wp063 | | |
Lizzie Beers | 016bb41f4ef | added cder_mpl1r_wp228 and cder_mpl1r_wp240 | | |
Ryan Schoeplein | 2741f44dc58 | Removed duplicate "cder_mpl2r_wp012" entry to Table of Contents | | |
Ryan Schoeplein | e560969bf40 | Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis | | |
Ryan Schoeplein | 443efd98363 | Added Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis | | |
Lizzie Beers | 9a8a8204821 | corrected a typo in the title of cder_mpl2p_wp011 | | |
Lizzie Beers | e03bbf3d036 | moved cder_mpl2p_wp011 to the top of the table of contents | | |
Lizzie Beers | 129ddf27207 | Added cder_mpl2p_wp024 | | |
Lizzie Beers | be16cef05f3 | Added Seizures following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis | | |
Ryan Schoeplein | d939d9519a2 | Added Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis | | |
Whitney Chlon | c3913861e27 | Added Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis | | |
Lizzie Beers | d48dde5829d | Added "cder_mpl2p_wp020 Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (an update to cder_mpl2p_wp012)" to the table of contents | | |
Lizzie Beers | 56c2b32933b | Fixed the table of contents formatting | | |
Lizzie Beers | df07b5a3209 | Added "cder_mpl2p_wp012 Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis" to table of contents | | |
Meredith Cantwell | 02586dc6b7a | Added Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis | | |
Regan Woodnutt | 23ac88c31c0 | Added Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis, Parts 1 and 2. | | |
Ryan Schoeplein | bdca9a754ce | Added Cutaneous Small-Vessel Vasculitis following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis | | |
Ryan Schoeplein | 905a102a3d3 | Added Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis | | |
Meredith Cantwell | 7e9e75b8fbd | Added A New Propensity Score Matched Analysis Tool for Pregnancy: Replicating A Study of Oral Clefts following Topiramate Use during the First Trimester of Pregnancy | | |
Meredith Cantwell | b5552a93e58 | Added Factors Related to the Assignment of Sodium Glucose Cotransporter-2 Inhibitors (SGLT-2i) versus Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) | | |
Ryan Schoeplein | deb59ef0aef | Added "Stroke, Intracranial Hemorrhage, and Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients Aged 65 or Older: A Propensity Score Matched Analysis" | | |